| abstract |
The invention relates to a medical product (100), in particular for use in the treatment, in particular the regenerative treatment, of cartilage damage and/or cartilage defects, comprising a foam-like component (110) and a membrane-like component (120) and/or a fibrous component (130). The invention further relates to a method for producing a medical product, wherein a reaction mixture for a foam-like component, said reaction mixture containing a foaming agent, is allowed to foam in the presence of a membrane-like component and preferably a fibrous component. |